top of page

NEWS AND EVENTS

May 7, 2024

Averto Medical Debuts with Oversubscribed $30M Series A Financing to Advance Innovative Medical Device that Avoids Need for Ostomy

Cormorant Asset Management leads financing with participation from Venrock Healthcare Capital Partners, LifeSci Venture Partners, CVF, and others; Ken Song, MD joins as Executive Chairman with Dan Puckett and Bihua Chen also joining the Board of Directors

Averto Medical Debuts with Oversubscribed $30M Series A Financing to Advance Innovative Medical Device that Avoids Need for Ostomy

Averto Medical is a privately held clinical stage medical technology company focused on solutions for patients suffering from gastrointestinal diseases 

bottom of page